ウイルス排除の世界市場：ウイルス検出、ウイルス除去、ウイルス不活性化...市場調査レポートについてご紹介

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions

3 Executive Summary (Page No. – 26)

4 Premium Insights (Page No. – 31)
4.1 Global Viral Clearance Market Overview
4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. – 35)
5.1 Introduction
5.1.1 Market Segmentation, By Application
5.1.2 Market Segmentation, By End User
5.1.3 Market Segmentation, By Method
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rapid Growth in Pharmaceutical and Biotechnology Industries
5.2.1.2 Increasing Number of New Drug Launches
5.2.1.3 Strong Trend of R&D Investments in the Life Sciences Industry
5.2.1.4 Increasing Government Support for Pharmaceutical and Biotechnology Industries
5.2.1.5 High Incidence and Large Economic Burden of Chronic Diseases
5.2.2 Restraints
5.2.2.1 High Degree of Consolidation to Act as A Major Barrier for New Entrants
5.2.3 Opportunities
5.2.3.1 Increasing Pharmaceutical Outsourcing
5.2.3.2 Developing Countries Present Significant Opportunities for the Viral Clearance Market
5.2.4 Challenges
5.2.4.1 Stringent Regulatory Frameworks and Time-Consuming Approval Processes

6 Viral Clearance Market, By Application (Page No. – 44)
6.1 Introduction
6.2 Vaccines and Therapeutics
6.3 Blood and Blood Products
6.4 Cellular and Gene Therapy Products
6.5 Tissue and Tissue Products
6.6 Stem Cell Products

7 Viral Clearance Market, By End User (Page No. – 54)
7.1 Introduction
7.2 Pharmaceutical and Biotechnology Companies
7.3 Contract Research Organizations
7.4 Academic Research Institutes
7.5 Other End Users

8 Viral Clearance Market, By Method (Page No. – 63)
8.1 Introduction
8.2 Viral Detection Method
8.2.1 Plaque Assays
8.2.2 Pcr
8.2.3 Elisa
8.2.4 Other Viral Detection Methods
8.3 Viral Removal
8.3.1 Chromatography
8.3.2 Nanofiltration
8.3.3 Precipitation
8.4 Viral Inactivation
8.4.1 Solvent Detergent Method
8.4.2 Pasteurization
8.4.3 Other Methods

9 Viral Clearance Market, By Region (Page No. – 86)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.4 Asia
9.5 Rest of the World

10 Competitive Landscape (Page No. – 126)
10.1 Overview
10.1.1 Strategic Overview
10.2 Leading Players in the Viral Clearance Market
10.3 Competitive Situation and Trends
10.3.1 Expansions
10.3.2 Agreements, Collaborations, and Partnerships
10.3.3 Acquisitions
10.3.4 Services Launches

11 Company Profiles (Page No. – 134)
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 Introduction
11.2 Charles River Laboratories International, Inc.
11.3 Lonza Group
11.4 Sigma-Aldrich Corporation
11.5 SGS S.A.
11.6 Wuxi Pharmatech (Cayman) Inc.
11.7 Avance Biosciences Inc.
11.8 BSL Bioservice
11.9 Clean Cells Inc.
11.10 Merck KGAA
11.11 Texcell, Inc.

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 156)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Introducing RT: Real-Time Market Intelligence
12.6 Available Customizations
12.7 Related Reports